Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Kuros Biosciences AG
KURNCurrent price
24.95 CHF
-6.03 CHF (-19.52%)
Last closed
31.25 CHF
Company
www.kuros.ch
ISIN
CH0325814116
Sector
Healthcare
Industry
Medical Devices
Exchange
SIX Swiss Exchange
Capitalization
1 049 887 034 CHF
Yield for 12 month
+541.39 %
1Y
3Y
5Y
10Y
15Y
KURN
Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through three segments: Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold use to fill bony voids for a predictable fusion; MagnetOs Easypack Putty, a ready-to-use mold to be implanted in any intervertebral disc space or posterolateral spine level; and Magnetos Flex Matrix, an open matrix bone graft. Its Fibrin-PTH pipeline products comprise KUR-111 and KUR-113 that are in Phase 2b clinical trials for trauma indications; KUR-113 that is in Phase 2a clinical trial for spinal indications. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland. Address: Wagistrasse 25, Schlieren, Switzerland, 8952
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
17.8 CHFP/E ratio
–Dividend Yield
–Current Year
+33 840 997 CHF
Last Year
+18 134 435 CHF
Current Quarter
+32 106 803 CHF
Last Quarter
+20 868 817 CHF
Current Year
+28 013 296 CHF
Last Year
+10 857 875 CHF
Current Quarter
+28 146 385 CHF
Last Quarter
+17 567 797 CHF
Key Figures KURN
1 year
3 years
5 years
10 years
EBITDA
-3 075 171 CHF
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-3.77 %
PEG Ratio
–
Return On Equity TTM
-14.32 %
Wall Street Target Price
17.8 CHF
Revenue TTM
52 975 619 CHF
Book Value
2.88 CHF
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
147.5 %
Dividend Yield
–
Gross Profit TTM
5 621 009 CHF
Earnings per share
-0.25 CHF
Diluted Eps TTM
-0.25 CHF
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-16.91 %
Dividend Analytics KURN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History KURN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:100
Payout Ratio
–
Last Split Date
23.06.2016
Dividend Date
08.10.2020
Stock Valuation KURN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
19.584
Price Sales TTM
19.8183
Enterprise Value EBITDA
-2.9303
Price Book MRQ
17.3044
Financials KURN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators KURN
For 52 weeks
3.09 CHF
30.05 CHF
50 Day MA
21.46 CHF
Shares Short Prior Month
–
200 Day MA
12.16 CHF
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart